ECM
HURA

Evergreen Capital Management’s TuHURA Biosciences HURA Stock Holding History

Evergreen Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14
Closed -$3K – 717
2022
Q3 		$3K Hold
14
– – ﹤0.01% 619
2022
Q2 		$7K Hold
14
– – ﹤0.01% 560
2022
Q1 		$10K Hold
14
– – ﹤0.01% 658
2021
Q4 		$13K Hold
14
– – ﹤0.01% 634
2021
Q3 		$21K Hold
14
– – ﹤0.01% 582
2021
Q2 		$56K Hold
14
– – ﹤0.01% 528
2021
Q1 		$43K Hold
14
– – ﹤0.01% 506
2020
Q4 		$32K Buy
+14
New +$35.1K ﹤0.01% 447

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Evergreen Capital Management's HURA Position: Q4 2022 in Review

Evergreen Capital Management sold out of TuHURA Biosciences (HURA) in Q4 2022, closing a stake of 14 shares — an estimated $3K sold.

Evergreen Capital Management first reported a position in HURA in Q4 2020 and held it in 8 quarters. The position peaked at $56K in Q2 2021. 10 funds tracked by Wall St. Rank hold HURA as of Q4 2022.

  • Evergreen Capital Management reported no remaining TuHURA Biosciences position as of Q4 2022 after selling out during the quarter.
  • Evergreen Capital Management sold 14 TuHURA Biosciences shares in Q4 2022, an estimated $3K.
  • Evergreen Capital Management first reported a position in TuHURA Biosciences in Q4 2020 and held it in 8 quarters.
  • Evergreen Capital Management's TuHURA Biosciences position peaked at $56K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2022.

Based on Evergreen Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.